Spartina Biotechnologies

Spartina Biotechnologies’ patent pending SIREN™ technology is a radical departure from traditional antiviral drugs and vaccines used to control Coronavirus. Spartina uses natural short interfering RNA (siRNA) to engage the suppressed activities of the RNAi pathway and to activate the antiviral interferon-mediated antiviral pathway.